Summary
Bilateral perfused hindlimb preparations in pentobarbital anesthetized dogs were utilized in the present study to evaluate vasodilator effects of felodipine, in the presence and in the absence of sympathetic neurogenic tone. Vascular resistance was evaluated by establishing pressure-flow characteristics. A lower dose of this agent (0.01 μmol/kg i.v.) produced significant reductions in the systemic arterial blood pressure and vascular resistance only in the innervated but not in the denervated limb. This effect was shown to be due to interference with noradrenaline induced vasoconstriction. However, a tenfold higher dose of felodipine (0.1 μmol/kg i.v.) was indeed effective in attenuating resistance in the denervated vascular bed; this ability of the higher dose (0.1 μmol/kg) to inhibit vascular resistance may be due to an additional intracellular action of this drug affecting myogenic tone and/or due to inhibition of the vascular effects of the endogenous renin-angiotensin system. In the present experimental model, felodipine, a dihydropyridine calcium antagonist, was equally effective in inhibiting either alpha1- or alpha2-mediated vasoconstriction. These data suggest that the ability of felodipine to interfere with sympathetic vasoconstrictor mechanisms primarily contributes to its hypotensive effects in the barbiturate-anesthetized dogs.
Similar content being viewed by others
References
Boström SL, Ljung B, Mårdh S, Forsen S, Thulin E (1981) Interaction of the antihypertensive drug felodipine with calmodulin. Nature 292:777–778
Cavero I, Shepperson N, Lefevre-Borg F, Langer SZ (1983) Differential inhibition of vascular smooth muscle responses to alpha1 and alpha2-adrenoceptor agonists by diltiazem and verapamil. Circ Res 52:69–76
Gerold M, Haeusler G (1983) Alpha2-adrenoceptors in rat resistance vessels. Naunyn-Schmiedeberg's Arch Pharmacol 322:29–33
Hallbäck-Norlander M, Dibona GF, Ljung B, Tai Y, Thoren P (1984) Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR. Eur J Pharmacol (in press)
Herlitz H, Aurell M, Conardson T (1983) Felodipine, an arteriolar dilator with pronounced antihypertensive effect. Lancet 1: 409–410
Jandhyala BS, Cavero I, Buckley JP (1972) Effects of prolonged hydrochlorothiazide administration on neurogenic tone in the hindlimb vasculature. Eur J Pharmacol 17:357–364
Jandhyala BS, Cavero I, Buckley JP (1976) Time-course effects of oral guanethidine administration on cardiovascular and autonomic effects on dogs. Eur J Pharmacol 36:21–32
Jandhyala BS, Kjellstedt A, Ljung B (1980) Does captopril lower arterial pressure due to inhibition of angiotensin I converting enzyme: Experimental studies in vivo and in vitro. Drug Exp Clin Res 6:557–567
Janis RA, Seriabine A (1983) Sites of action of Ca2+ channel inhibitors. Biochem Pharmacol 32:3499–3507
Johnsson G, Murray G, Tweddel A, Hutton I (1983) Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects. Eur J Clin Pharmacol 24:49–53
Kalkman HO, Martin JMC, Thoolen P, Timmermans PBMWM, Van Zwieten PA (1984) The influence of alpha1 and alpha2-adrenoceptor agonists on cardiac output in rats and cats. J Pharm Pharmacol 36:265–268
Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, Zanchetti A (1984) Felodipine, a new vasodilating drug: Blood pressure, cardiac renal and humoral effects in hypertensive patients. J Cardiovasc Pharmacol 6:392–398
Ljung B (1985) Vascular selectivity of felodipine. Drugs 29 (Suppl 2):46–58
Lokhandwala MF, Kivlighn SD, Jandhyala BS (1984) Characterization of neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide. J Pharmacol Exp Ther 228:696–703
Mohammed S, Gaffney TE, Yard AC, Gomez H (1968) Effects of methyldopa, reserpine and guanethedine on hindleg vascular resistance. J Pharmacol Exp Ther 160:300–307
Peter EJ, Steenberg ML, Lokhandwala MF, Jandhyala BS, Eikenburg DC (1985) Influence of felodipine and verapamil on the sympathetic transmitter release and on the pre- and postjunctional effects of exogenous norepinephrine in the perfused rat kidney. Drugs 29 (Suppl 2):198–204
Saeed M, Holtz J, Elsner D, Bassenge E (1983) Attenuation of sympathetic vasoconstriction by nifedipine: The role of vascular alpha2-adrenoceptors. Eur J Pharmacol 94:149–153
Saida K, Van Breemen C (1983) Mechanism of Ca2+ antagonist induced vasodilation: Intracellular actions. Circ Res 52:137–142
Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78
Steppeler A, Tanaka T, Starke K (1978) A comparison of pre- and postsynaptic alpha-adrenergic effects of phenylephrine and tramazoline on blood vessels of the rabbit in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 304:223–230
Timmermans PBMWM, Mathy MJ, Wilfert B, Kalkman HO, Thoolen MJMC, de Jonge A, Van Meel JCA, Van Zwieten PA (1983) Differential effect of calcium entry blockers on alpha1-adrenoceptor-mediated vasoconstriction in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 324:239–245
Van Meel JCA, Timmermans PBMWM, Van Zwieten PA (1983) Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha2-adrenoceptor mediated vasopressor responses. Eur J Pharmacol 92:27–34
Van Zwieten PA, Van Meel JCA, Timmermans PBMWM (1983) Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha2-adrenoceptors. Circ Res 52:77–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jandhyala, B.S. Studies on the effects of felodipine on the vascular resistance and reactivity in pentobarbital anesthetized dogs. Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 398–403 (1985). https://doi.org/10.1007/BF00496375
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00496375